Dilantin is one of America’s oldest and most popular antiepileptic drugs, treating patients who suffer a variety of different seizures.
Unfortunately this drug has been associated with a number of severe side effects including Stevens Johnson Syndrome, focal cerebral atrophy, and cerebellar ataxia.
Cerebellar toxicity is one of the most dangerous side effects allegedly associated with Dilantin, as there is no known cure. In addition, the chronic pain and immobility associated with cerebral damage effects the patient’s every day life, with no way to reverse it.
In a recent study released in the March 2013 issue of Neurology Asia, researchers examine the extent of the nerve damage Dilantin (phenytoin) can induce in the brain. More specifically the study examined Dilantin’s association with cerebellar ataxia, which is a condition that occurs when the cerebellum becomes inflamed or damaged in some way.
This often results in the patient’s gait being unstable, due to loss of muscle coordination. While cerebellar complications have long been a concern associated with Dilantin focal cerebral atrophy, irreversible cerebellar dysfunction conditions like cerebellar ataxia is quite rare.
Focal cerebral atrophy occurs when brain tissue becomes damaged or loses neurons, which disrupts the travel path of the electrical signals. Oftentimes when this condition occurs, cerebellum damage can be expected, which ultimately effects the patient’s voluntary movements, balance, coordination, and speech.
Dilantin Focal Cerebral Atrophy Complications
The Neurology Asia study examined a 20-year-old female patient who had been prescribed Dilantin, and had suffered this severe complication. Symptoms that came along with her cerebellar ataxia included: reduced attention, slow responses, dulled speech, and executive dysfunction.
The patient started experiencing these side effects two weeks after she was prescribed Dilantin, with diagnostic images indicating that she suffered long-term cognitive and physical dysfunction from focal cerebral atrophy six months later.
The study ultimately indicated that Dilantin was most likely the cause for the patient’s coordination issues and cerebellum damage. There are several cerebral atrophy treatment options, with minor cases being possible to cure from simply ceasing Dilantin.
In severe cases, the only option of focal cerebral atrophy treatment available could be chronic therapy to help patients contend with the symptoms. While there are a number of focal cerebral atrophy causes, using Dilantin has been indicated as one of the triggers.
Studies indicate that long-term exposure of this drug significantly increases the risk of focal cerebral atrophy, but this condition has appeared in cases of normal exposure levels.
It is important to note that seizures are also a part of the possible cerebral atrophy causes, according to a 1994 study published in Archives of Neurology. This is interesting as patients are often prescribed Dilantin to treat seizures, which prompted researchers to conduct the study.
Researchers “found a group difference between the phenytoin-exposed epilepsy population and the controls, as the patients had significantly smaller cerebelli.” This essentially means that patients suffering from seizures and not on Dilantin, could also be at risk for focal cerebral atrophy.
At this time, Dilantin patients are encouraged to speak with their physicians if they start experiencing any adverse side effects.
In general, phenytoin lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Dilantin lawsuit or Dilantin class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Dilantin, Phenytoin Cerebral Atrophy Class Action Lawsuit Investigation
If you or a loved one were injured by Dilantin/phenytoin side effects, you may have a legal claim. Fill out the form for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Please list an emergency contact's name and phone number:*
- What is the best time to call you?*
- Please select the drug you/your loved on took:*
-
Phenytoin
-
Dilantin
-
Other (please describe in the Additional Details box below)
-
- What year(s) did you/your loved one take this drug?*
- Which of the following were you/your loved one medically diagnosed with?*
-
Cerebellar atrophy
-
No medical diagnosis
-
Other (please describe in the Additional Details box below)
-
- Please enter any additional details you would like the staff reviewing your submission to know.*
- Have you already retained an attorney to file a phenytoin lawsuit?*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
- ¿Necesita un orador español?
- Yes
- No
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 162) {gformInitChosenFields(‘#input_162_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_162_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_162_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [162, 1]) } );
The post Dilantin Case Study Reveals Dangers of Focal Cerebral Atrophy appeared first on Top Class Actions.
Read our Dilantin cerebral atrophy research at www.dilantinlawyers.org Dilantin is our law speciality 855-496-6059
ReplyDelete